Biostatistician — Division of Bioinformatics and Biostatistics

Paul Rogers, Ph.D.
(870) 543-7121
[email protected]  

Back to NCTR Principal Investigators page

 About  |  Publications

Background

Dr. Paul Rogers received a Bachelor of Science in mathematics and a master’s degree and Ph.D. in biostatistics from the University of Oklahoma. His work experience is broad, ranging from building enterprise-wide systems as a computer scientist to performing statistical consulting and research epidemiology. He joined FDA’s National Center for Toxicological Research (NCTR) in January 2020 as a biostatistician in the Biostatistics Branch of the Division of Bioinformatics and Biostatistics.

Research Interests

Dr. Rogers's expertise and experience are in computational epidemiology, high-performance computing, generalized estimating equations, scientific information systems, geographic information systems (GIS), research database applications, and statistical software. In addition, his interests include population-based research, pharmacoepidemiology, rare-event modeling, and applications of GIS to epidemiology. Currently, he is conducting research with the National Health and Nutrition Examination Survey on nonsteroidal anti-inflammatory drugs, associated risk factors, and prevalence within the US population.

Professional Societies/National and International Groups

American Statistical Association
Member
2014 — Present

Royal Statistical Society
Member
2010 — Present

Select Publications/Reports

Assessment of a Modified Sandwich Estimator for Generalized Estimating Equations with Application to Opioid Poisoning in MIMIC-IV ICU Patients.
Rogers P.B. and Stoner J.A.
Stats. 2021, 4(3), 650-664. https://doi.org/10.3390/stats4030039.

Medical Information Mart for Intensive Care: A Foundation for the Fusion of Artificial Intelligence and Real-World Data.
Rogers P.B., Wang D., and Lu Z.
Front. Artif. Intell. 2021, https://doi.org/10.3389/frai.2021.691626.

The Use of a Poisson Regression to Evaluate Antihistamines and Fatal Aircraft Mishaps in IMC.
Gildea K., Hileman C., Rogers P.B., and Salazar G.
Aerosp Med Hum Perform. 2018, 89(4):389-395. doi: 10.3357/AMHP.4828.2018.

Pilots Using Selective Serotonin Reuptake Inhibitors Compared to Other Fatally Injured Pilots.
Rogers P.B., Hileman C., Guillermo G., Cliburn K., Paskoff L., Hathaway W., Gildea K., and Villala V.H.T.
Accid Anal Prev. 2017, 107:86-91. doi: 10.1016/j.aap.2017.07.023. Epub 2017 Aug.12.

Development of a Geographic Information System for Risk-Informed Decision Making in Aerospace Medicine.
Paskoff L. and Rogers P.B.
Aerosp Med Hum Perform. 2016, 87(11):972-975. doi: 10.3357/AMHP.4751.2016.

Ethanol and Drugs Found in Civil Aviation Accident Pilot Fatalities, 1989-2013.
Chaturvedi A.K., Craft K.J., Hickerson J.S., and Rogers P.B.
Aerosp Med Hum Perform. 2016, 87(5):470-6. doi: 10.3357/AMHP.4490.2016.

Modification of the Sandwich Estimator in Generalized Estimating Equations with Correlated Binary Outcomes in Rare Event and Small Sample Settings.
Rogers P.B.  and Stoner J.A.
Am J Appl Math Stat. 2015, 3(6):243-251. doi: 10.12691/ajams-3-6-5.

The +Gz Recovery of Consciousness Curve.
Whinnery T., Forster E., and Rogers P.
Extrem Physiol Med. 2014, 3:9. doi: 10.1186/2046-7648-3-9. eCollection 2014.

Toxicological Findings in Fatally Injured Pilots of 979 Amateur-Built Aircraft Accidents.
Chaturvedi A.K., Craft K.J., Hickerson J.S., Rogers P.B., and Soper J.W.
Aviat Space Environ Med. 2013, 84(2):134-41. doi: 10.3357/asem.3285.2013.

Increased Cannabinoids Concentrations Found in Specimens from Fatal Aviation Accidents Between 1997 and 2006.
Canfield D., Dubowski K., Whinnery J., Lewis R., Ritter R., and Rogers P.
Forensic Sci Int. 2010, 197(1-3):85-8. doi: 10.1016/j.forsciint.2009.12.060. Epub 2010 Jan 13.

Evaluating Probabilistic Risk Assessment Methodology for use in the Medical Certification of Airmen.
Rogers P.B.
Aviat Space Environ Med. 2009, 80(10):904-5. doi: 10.3357/asem.21008.2009.

The FAA’s Postmortem Forensic Toxicology Proficiency-Testing Program; the Second Seven Years.
Chaturvedi A.K., Craft C.J., Cardona P.S., Rogers P.B., and Canfield D.V.
J Anal Toxicol. 2009, 33(4):229-36. doi: 10.1093/jat/33.4.229.

Comprehensive Healthcare Inspection Summary Report Fiscal Year 2018.
Toy M., Clegg L., Hanlon J., Harvey H., Henry L., Yoonhee K., McGrath S., Rogers P.B., Ross L., Smith P., Stones M., Wallace R., and Yu J.
VA OIG. 2019: Report #19-07040-243.

Descriptive Characteristics of Atrial Fibrillation in Civil Aviation 1993-2005.
Verroneau S. and Rogers P.B.
Office of Aerospace Medicine. 2017: DOT/FAA/AM-17/10.

Fatal Aviation Accidents: Fiscal Years 2009-2013.
Hileman C., McNeil C., and Rogers P.B.
Office of Aerospace Medicine. 2015: DOT/FAA/AM-15/19.

Prevalence of Ethanol and Drugs in Civil Aviation Accident Pilot Fatalities, 2009-2013.
Chaturvedi A.K., Craft K.J., Hickerson J.S., Rogers P.B., and Canfield D.V.
Office of Aerospace Medicine. 2015: DOT/FAA/AM-15/13.

Risk in the US Pilot Population from 1983-2005; Diabetes Prevalence and Flight Safety.
Rogers P.B., Verroneau S., and Forster E.
Office of Aerospace Medicine. 2015: DOT/FAA/AM-15/5.

An Analysis of the U.S. Pilot Population From 1983-2005: Evaluating the Effects of Regulatory Change.
Rogers P., Veronneau S., Peterman C., Whinnery J., and Forster E.M.
Office of Aerospace Medicine. 2009: DOT/FAA/AM-09/9.

The Second Seven Years of the FAA’s Postmortem Forensic Toxicology Proficiency-Testing Program.
Chaturvedi A.K., Craft C.J., Cardona P.S., Rogers P.B., and Canfield D.V.
Office of Aerospace Medicine. 2008: DOT/FAA/AM-08/24.

Development of an Aeromedical Scientific Information System for Aviation Safety.
Peterman C., Rogers P., Veronneau S., and Whinnery J.
Office of Aerospace Medicine. 2008: DOT/FAA/AM-08/1.